Indian Pharmas Look To Herbal Medicines As Huge Potential (India)
This article was originally published in PharmAsia News
Executive Summary
India's $1 billion herbal medicine industry is expected to grow by as much as 15 percent a year as pharmaceutical companies see its potential. Much of the interest is in Western countries, with Indians slow to rely on the alternative drugs. Prescription herbal medicine accounts for only 30 percent of the market for Indian companies, with the other 70 percent over-the-counter products. Prescription herbal medicine generally lack clinical-trial data, with those backed by accepted research selling the best in India, which is one of the largest producers of medicinal herbs. One drug company executive said many pharmaceutical companies see herbal health care as having huge potential. (Click here for more
You may also be interested in...
CDER, CBER Not Seeing Hiring Slowdown Despite US FDA Warnings
FDA officials have said hiring could be slowed if an inflationary pay increase is not included in the agency budget, but CDER and CBER continue to add staff at a steady pace.
Medicare Reimbursement For Part B Drugs Is 48% Above 340B Prices To Hospitals, MedPAC Finds
New study updates past commission analyses and highlights the significant margin between Medicare payments for drugs and the prices paid by 340B-eligible providers.
Drug Shortages, Inspections In Focus At US FDA Appropriations Hearing
Commissioner Robert Califf discussed the agency’s request for $12.3m to address shortages and legislation to require that manufacturers provide more detailed information about increased demand and supply chain vulnerabilities.